Netupitant
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09048 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 73 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | leprosy | KG + DL |
| 3 | migraine disorder | KG + DL |
| 4 | migraine with or without aura, susceptibility to | KG + DL |
| 5 | pulmonary hypertension | KG + DL |
| 6 | migraine with brainstem aura | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | hyperargininemia | KG + DL |
| 9 | coronary artery disease | KG + DL |
| 10 | hypertrichosis (disease) | KG + DL |
| 11 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 12 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 13 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 14 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 15 | isolated genetic hair shaft abnormality | KG + DL |
| 16 | myocardial ischemia | KG + DL |
| 17 | atrophoderma vermiculata | KG + DL |
| 18 | persistent Mullerian duct syndrome | KG + DL |
| 19 | ulerythema ophryogenesis | KG + DL |
| 20 | genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability | KG + DL |
| 21 | mycotic corneal ulcer | KG + DL |
| 22 | homozygous familial hypercholesterolemia | KG + DL |
| 23 | multiple endocrine neoplasia | KG + DL |
| 24 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 25 | oral candidiasis | KG + DL |
| 26 | carbamoyl phosphate synthetase I deficiency disease | KG + DL |
| 27 | commissural lip fistula | KG + DL |
| 28 | osteoradionecrosis of the mandible | KG + DL |
| 29 | oral leukoedema | KG + DL |
| 30 | burning mouth syndrome | KG + DL |
| 31 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 32 | fascioliasis | KG + DL |
| 33 | cardiovascular disease | KG + DL |
| 34 | nephrogenic diabetes insipidus | KG + DL |
| 35 | collagenopathy | KG + DL |
| 36 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 37 | uterine polyp | KG + DL |
| 38 | Laubry-Pezzi syndrome | KG + DL |
| 39 | adult-onset citrullinemia type I | KG + DL |
| 40 | acute neonatal citrullinemia type I | KG + DL |
| 41 | benign shuddering attacks | KG + DL |
| 42 | extrapyramidal and movement disease | KG + DL |
| 43 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 44 | chronic tic disorder | KG + DL |
| 45 | Jeune syndrome situs inversus | KG + DL |
| 46 | female breast carcinoma | KG + DL |
| 47 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 48 | coronary atherosclerosis | KG + DL |
| 49 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 50 | rheumatoid arthritis | KG + DL |
(Showing top 50 of 73 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.